Company Summary

Opsona Therapeutics Limited was set up on Tuesday the 9th of March 2004. Their current address is 2nd Floor Ashford House,Tara Street,Dublin 2, and the company status is Strike Off Listed. The company has 9 directors who have also been the director of 13 other Irish companies between them. Opsona Therapeutics Limited has 26 shareholders. This Irish company shares its Eircode with at least 8 other companies.

Company Name:Opsona Therapeutics Limited
Company Status:STRIKE OFF LISTED
Company Address:2nd Floor Ashford House,
Tara Street,
Dublin 2
Telephone:+353 (0)1 677 0223
Website:www.opsona.com
Key Executive:Luke O'Neill
Company Size:Log-In To View
Disclaimer Other Details
Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us.

Key Contact Profile

Luke O'Neill is a Company Director of Opsona Therapeutics Limited since 2007 and a listed Director of 3 other companies.

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Opsona Therapeutics Limited (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
B1 ANNUAL RETURN09/09/201604/01/2018Join Up
ACCOUNT DETAILS31/12/201504/01/2018Join Up
OTHER DIRECTORSHIP LIST09/09/201604/01/2018Join Up
B7 NOTICE OF CONSOLIDATION, DIVISION, CONVERSION20/12/201721/12/2017Join Up
NOTICE OF INCREASE IN NOMINAL CAPITAL20/12/201721/12/2017Join Up
THIS COMPANY HAS 162 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Opsona Therapeutics Limited.

Company Status:Strike Off Listed
Latest Credit Movement:
Date of Last Movement:18/06/2018
Latest Accounts Filed:04/01/2018
Report Based on Accounts:31/12/2015
Next Set of Accounts Due:09/09/2017
Overdue:Yes
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Opsona Therapeutics Limited simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors

Satisfy due diligence requirments on Opsona Therapeutics Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Opsona Therapeutics Limited and Anti-Money Laundering checks (AML checks) on Opsona Therapeutics Limited

Director:Peter Arthur James Benson
Director:Bernd Robert Seizinger
Other Directors:Opsona Therapeutics Limited has 7 other Directors.

Ownership Structure

Company Type:LTD - Private Company Limited By Shares
Number of Shareholders:26

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Opsona Therapeutics Limited or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

The Key Business Trends of Q1-2018

01/05/2018

Company start-ups remain strong while insolvencies fall in the first quarter of 2018

Read More »

The 2018 Annual Review

01/05/2018

2017 was a record year for company start-ups in Ireland while insolvencies went through a levelling off period.

Read More »

The 2017 Annual Review

08/02/2018

We are in acceleration mode and Ireland has taken its place as Europe's fastest growing economy. Many aspects of that recovery are demonstrated in our 2017 Annual Review.

Read More »

Company Announcement - Vision-net.ie, A CRIF Company

08/01/2018

Vision-net has been acquired by leading fintech company, CRIF.

Read More »